Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
|
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
  • [41] Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients
    Raquel Samões
    Sandrina Carvalho
    Rosário Alves
    Tiago Torres
    Ana Martins Silva
    European Journal of Dermatology, 2014, 24 : 411 - 412
  • [42] Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis
    Kornek, B
    Bernert, G
    Balassy, C
    Geldner, J
    Prayer, D
    Feucht, M
    NEUROPEDIATRICS, 2003, 34 (03) : 120 - 126
  • [43] Glatiramer acetate (GLAT) - Induced immune activation in patients with multiple sclerosis
    Windhagen, A
    Maniak, S
    Trebst, C
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    NEUROLOGY, 2000, 54 (07) : A276 - A276
  • [44] Clinical course of multiple sclerosis in Japanese patients treated with glatiramer acetate
    Okamoto, T.
    Lin, Y.
    Araki, M.
    Sato, W.
    Kawazoe, T.
    Wakasugi, N.
    Takewaki, D.
    Takahashi, Y.
    Yamamura, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 793 - 794
  • [45] Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients
    Samoes, Raquel
    Carvalho, Sandrina
    Alves, Rosario
    Torres, Tiago
    Silva, Ana Martins
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (03) : 411 - 412
  • [46] Time Course of Glatiramer Acetate Efficacy in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) in the Glatiramer Acetate Low-Frequency Administration (GALA) Study
    Kolodny, S.
    Davis, M. D.
    Ashtamker, N.
    Steinerman, J. R.
    Knappertz, V.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 333 - 334
  • [47] Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis (vol 72, pg 1411, 2015)
    Bourdette, D.
    Hartung, D.
    JAMA NEUROLOGY, 2015, 72 (12) : 1537 - 1537
  • [48] Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis A Randomized Clinical Trial
    Cree, Bruce A. C.
    Goldman, Myla D.
    Corboy, John R.
    Singer, Barry A.
    Fox, Edward J.
    Arnold, Douglas L.
    Ford, Corey
    Weinstock-Guttman, Bianca
    Bar-Or, Amit
    Mientus, Susanne
    Sienkiewicz, Daniel
    Zhang, Ying
    Karan, Rajesh
    Tenenbaum, Nadia
    JAMA NEUROLOGY, 2021, 78 (01) : 48 - 60
  • [49] Use of glatiramer acetate (copaxone) in treatment of patients with multiple sclerosis Experience of the Moscow multiple sclerosis centre
    Demina, TL
    Davydovskaya, MV
    Lasch, NY
    Popova, NF
    Khachanova, NV
    Zhuchenko, TD
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, : 91 - 97
  • [50] Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis - A pilot study
    Farina, C
    Wagenpfeil, S
    Hohlfeld, R
    JOURNAL OF NEUROLOGY, 2002, 249 (11) : 1587 - 1592
12345